Contact
Please use this form to send email to PR contact of this press release:
Helsinn Group and MEI Pharma Discontinue the Phase 3 Study with Pracinostat in AML after Completing Interim Analysis
TO:
Please use this form to send email to PR contact of this press release:
Helsinn Group and MEI Pharma Discontinue the Phase 3 Study with Pracinostat in AML after Completing Interim Analysis
TO: